ID

17874

Beschreibung

Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00386373

Link

https://clinicaltrials.gov/show/NCT00386373

Stichworte

Versionen (2)
  1. 06.10.16 06.10.16 -
  2. 06.10.16 06.10.16 -
Hochgeladen am

6. Oktober 2016

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Leukemia NCT00386373

Englisch

Eligibility Leukemia NCT00386373

1 Formulare  
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00386373
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
1. patients with ph(+) cml and/or cml with bcr-abl rearrangement and diploid cytogenetics not eligible for protocols of higher priority (e.g. id02-901, dm99-081, dm97-206, etc).
Beschreibung

Philadelphia chromosome positive chronic myelogenous leukemia | Myeloid Leukemia, Chronic | BCR-ABL Fusion Gene Rearrangement | Cytogenetic Analysis Diploidy

Datentyp

boolean

Alias
UMLS CUI [1]
C0279543
UMLS CUI [2]
C0023473
UMLS CUI [3,1]
C1835417
UMLS CUI [3,2]
C0017287
UMLS CUI [4,1]
C0752095
UMLS CUI [4,2]
C0012568
2. the disease must be beyond first chronic phase according to ibmtr criteria (i.e. accelerated phase, blastic phase, second chronic phase) at the time of transplant.
Beschreibung

Disease Chronic phase Ordinal number | Accelerated phase | Blastic Phase | Chronic phase second

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0012634
UMLS CUI [1,2]
C0457343
UMLS CUI [1,3]
C0439080
UMLS CUI [2]
C0457345
UMLS CUI [3]
C3899938
UMLS CUI [4,1]
C0457343
UMLS CUI [4,2]
C0205436
3. patients with ph(+) acute lymphocytic (or myeloid) leukemia.
Beschreibung

Philadelphia chromosome-positive acute lymphoblastic leukemia | Philadelphia chromosome positive Acute Myelocytic Leukemia

Datentyp

boolean

Alias
UMLS CUI [1]
C1960397
UMLS CUI [2,1]
C0023467
UMLS CUI [2,2]
C0856536
4. patients with diploid cytogenetics but molecular evidence of bcr-abl rearrangement are also eligible.
Beschreibung

Cytogenetic Analysis Diploidy | BCR-ABL Fusion Gene Rearrangement Evidence Molecular

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0752095
UMLS CUI [1,2]
C0012568
UMLS CUI [2,1]
C1835417
UMLS CUI [2,2]
C0017287
UMLS CUI [2,3]
C3887511
UMLS CUI [2,4]
C1521991
5. age >/= 16 years
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
6. unsupported anc at least 1500 and unsupported platelet count of at least 50k following bmt.
Beschreibung

Absolute neutrophil count | Platelet Count measurement | Bone Marrow Transplantation

Datentyp

boolean

Alias
UMLS CUI [1]
C0948762
UMLS CUI [2]
C0032181
UMLS CUI [3]
C0005961
7. patients may have received prior chemotherapy for their disease or be previously untreated.
Beschreibung

Prior Chemotherapy Disease | Patients untreated

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1514457
UMLS CUI [1,2]
C0012634
UMLS CUI [2,1]
C0030705
UMLS CUI [2,2]
C0332155
8. patients must have received an allogeneic bone marrow or stem cell transplant. allogeneic transplant types may include matched sibling donors, mismatched related donors, or unrelated donors. all preparative regimens acceptable.
Beschreibung

Allogeneic bone marrow transplantation | Allogeneic Stem Cell Transplantation | Transplant type allogeneic | Tissue Donors Sibling HLA Matched | Living related donor Mismatch | Unrelated Donors | Preparative Regimen

Datentyp

boolean

Alias
UMLS CUI [1]
C0149615
UMLS CUI [2]
C2242529
UMLS CUI [3,1]
C3840412
UMLS CUI [3,2]
C1515895
UMLS CUI [4,1]
C0040288
UMLS CUI [4,2]
C0037047
UMLS CUI [4,3]
C1548978
UMLS CUI [5,1]
C3494891
UMLS CUI [5,2]
C1881865
UMLS CUI [6]
C3179133
UMLS CUI [7]
C1882454
9. signed informed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
10. zubrod status </= 3
Beschreibung

Zubrod Performance Status

Datentyp

boolean

Alias
UMLS CUI [1]
C3714786
11. adequate hepatic (bilirubin </= 3 mg/dl, transaminases < 4 x upper limit of normal) and renal function (serum creatinine </= 3 mg/dl )
Beschreibung

Liver function | Serum total bilirubin measurement | Transaminases | Renal function | Creatinine measurement, serum

Datentyp

boolean

Alias
UMLS CUI [1]
C0232741
UMLS CUI [2]
C1278039
UMLS CUI [3]
C0002594
UMLS CUI [4]
C0232804
UMLS CUI [5]
C0201976
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
1. grade iii/iv cardiac problems as defined by the nyhac
Beschreibung

Heart Diseases | New York Heart Association Classification

Datentyp

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C1275491
2. history of hypersensitivity to imatinib
Beschreibung

Hypersensitivity imatinib

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0935989
3. pregnant and lactating women
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
4. hiv positive
Beschreibung

HIV Seropositivity

Datentyp

boolean

Alias
UMLS CUI [1]
C0019699
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Leukemia NCT00386373

1 Formulare
  1. StudyEvent: Eligibility
    1. Eligibility Leukemia NCT00386373
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Philadelphia chromosome positive chronic myelogenous leukemia | Myeloid Leukemia, Chronic | BCR-ABL Fusion Gene Rearrangement | Cytogenetic Analysis Diploidy
Item
1. patients with ph(+) cml and/or cml with bcr-abl rearrangement and diploid cytogenetics not eligible for protocols of higher priority (e.g. id02-901, dm99-081, dm97-206, etc).
boolean
C0279543 (UMLS CUI [1])
C0023473 (UMLS CUI [2])
C1835417 (UMLS CUI [3,1])
C0017287 (UMLS CUI [3,2])
C0752095 (UMLS CUI [4,1])
C0012568 (UMLS CUI [4,2])
Disease Chronic phase Ordinal number | Accelerated phase | Blastic Phase | Chronic phase second
Item
2. the disease must be beyond first chronic phase according to ibmtr criteria (i.e. accelerated phase, blastic phase, second chronic phase) at the time of transplant.
boolean
C0012634 (UMLS CUI [1,1])
C0457343 (UMLS CUI [1,2])
C0439080 (UMLS CUI [1,3])
C0457345 (UMLS CUI [2])
C3899938 (UMLS CUI [3])
C0457343 (UMLS CUI [4,1])
C0205436 (UMLS CUI [4,2])
Philadelphia chromosome-positive acute lymphoblastic leukemia | Philadelphia chromosome positive Acute Myelocytic Leukemia
Item
3. patients with ph(+) acute lymphocytic (or myeloid) leukemia.
boolean
C1960397 (UMLS CUI [1])
C0023467 (UMLS CUI [2,1])
C0856536 (UMLS CUI [2,2])
Cytogenetic Analysis Diploidy | BCR-ABL Fusion Gene Rearrangement Evidence Molecular
Item
4. patients with diploid cytogenetics but molecular evidence of bcr-abl rearrangement are also eligible.
boolean
C0752095 (UMLS CUI [1,1])
C0012568 (UMLS CUI [1,2])
C1835417 (UMLS CUI [2,1])
C0017287 (UMLS CUI [2,2])
C3887511 (UMLS CUI [2,3])
C1521991 (UMLS CUI [2,4])
Age
Item
5. age >/= 16 years
boolean
C0001779 (UMLS CUI [1])
Absolute neutrophil count | Platelet Count measurement | Bone Marrow Transplantation
Item
6. unsupported anc at least 1500 and unsupported platelet count of at least 50k following bmt.
boolean
C0948762 (UMLS CUI [1])
C0032181 (UMLS CUI [2])
C0005961 (UMLS CUI [3])
Prior Chemotherapy Disease | Patients untreated
Item
7. patients may have received prior chemotherapy for their disease or be previously untreated.
boolean
C1514457 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C0030705 (UMLS CUI [2,1])
C0332155 (UMLS CUI [2,2])
Allogeneic bone marrow transplantation | Allogeneic Stem Cell Transplantation | Transplant type allogeneic | Tissue Donors Sibling HLA Matched | Living related donor Mismatch | Unrelated Donors | Preparative Regimen
Item
8. patients must have received an allogeneic bone marrow or stem cell transplant. allogeneic transplant types may include matched sibling donors, mismatched related donors, or unrelated donors. all preparative regimens acceptable.
boolean
C0149615 (UMLS CUI [1])
C2242529 (UMLS CUI [2])
C3840412 (UMLS CUI [3,1])
C1515895 (UMLS CUI [3,2])
C0040288 (UMLS CUI [4,1])
C0037047 (UMLS CUI [4,2])
C1548978 (UMLS CUI [4,3])
C3494891 (UMLS CUI [5,1])
C1881865 (UMLS CUI [5,2])
C3179133 (UMLS CUI [6])
C1882454 (UMLS CUI [7])
Informed Consent
Item
9. signed informed consent
boolean
C0021430 (UMLS CUI [1])
Zubrod Performance Status
Item
10. zubrod status </= 3
boolean
C3714786 (UMLS CUI [1])
Liver function | Serum total bilirubin measurement | Transaminases | Renal function | Creatinine measurement, serum
Item
11. adequate hepatic (bilirubin </= 3 mg/dl, transaminases < 4 x upper limit of normal) and renal function (serum creatinine </= 3 mg/dl )
boolean
C0232741 (UMLS CUI [1])
C1278039 (UMLS CUI [2])
C0002594 (UMLS CUI [3])
C0232804 (UMLS CUI [4])
C0201976 (UMLS CUI [5])
Item Group
C0680251 (UMLS CUI)
Heart Diseases | New York Heart Association Classification
Item
1. grade iii/iv cardiac problems as defined by the nyhac
boolean
C0018799 (UMLS CUI [1])
C1275491 (UMLS CUI [2])
Hypersensitivity imatinib
Item
2. history of hypersensitivity to imatinib
boolean
C0020517 (UMLS CUI [1,1])
C0935989 (UMLS CUI [1,2])
Pregnancy | Breast Feeding
Item
3. pregnant and lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
HIV Seropositivity
Item
4. hiv positive
boolean
C0019699 (UMLS CUI [1])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video